Father : Aaron Eaby Martin (born 1935) / Mother : Ruth Parsons ..
Maternal Grandfather : William Herbert Parsons (born 1904)
Maternal Great-grandfathers : William Herbert Parsons (born 1868) / Jesse Courtney Suter Sr. (born 1872)
Siblings : Daniel William Martin (born 1962)
R. Buckminster Fuller wrote of himself, “I live on Earth at present, and I don’t know what I am. I know that I am not a category. I am not a thing — a noun. I seem to be a verb, an evolutionary process — an integral function of Universe.” For most people, their next question was, “Who is this guy?”
Dr. David Martin knows who he is. And he’s here to show others how to remember what it means to put humanity into the human experience. Over the past 5 decades he’s fully lived and has done so in service to humanity. Unlike many who build an identity around accomplishments, he uses his actions to show others the vast extremes of possibility.
His first invention was a laser integrated system to target and treat inoperable tumors. His mathematics helped unravel the way the human body processes hormones and led to the detection and treatment of many diseases. His observation of human behavior led to his development of technology which deciphers the intention and motivation of communication – a technology that has impacted and saved the lives of billions. His global business activities served to develop the world’s top-performing global equity index (including the CNBC IQ100 powered by M·CAM). He’s brought the world’s largest white-collar criminals to justice and brought the world’s most oppressed and disenfranchised transformative ways to engage. From the starry expanses of Mongolia to the flashing lights of New York, his work is as passion-filled whether it’s with a camel herder or a global CEO.
He tells his own story in the critically acclaimed documentary Future Dreaming and breaks down economic injustice in Patent Wars. An author, public speaker, business visionary, professor, researcher, oracle, father, and friend, David is a man Fully Living. He is the author of Coup d’Twelve.
Equipped with his Integral Accounting insights and his Breathing Enterprise implementation, what’s happening today is more interesting than everything before. And the best thing of all is that, if you’d like to experience what it’s like to be fully living, you can be part of the action! Together with Kim Martin – the woman that taught him some of his most important lessons about fully living – and a core team of masterful colleagues, you too can step into the full essence of what it means to Fully Live!
M•CAM / Chairman / Oct 1998 - Present · 24 yrs 11 mos / Charlottesville, Virginia Area
University of Virginia / PhD, Physiology / Sports Medicine / 1992 - 1995
Ball State University / MS, Physiology / 1990 - 1992
Included extensive work in the Human Performance Laboratory
Goshen College / BA, Biology, Psychology, Sports Medicine / 1985 - 1989
SST in Costa Rica during the latter stages of the Nicaraguan War
Name : David E Martin
Age : 20 / Birth Year : abt 1967
Residence County : Out of State
Spouse's Name : Colleen C Caskey
Spouse's Age : 22 / Spouse's Birth Year : abt 1965
Spouse's Residence County : Out Of State
Marriage Date : 19 Dec 1987
Marriage License County : Allen
Certificate Number : 85334
Volume Number : 13571
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317786/?page=1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317786/pdf/jathtrain00027-0010.pdf
jathtrain00027-0010.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1319231/
J Athl Train. 1997 Jan-Mar; 32(1): 25–28.
PMCID: PMC1319231 / PMID: 16558428
"David E. Martin, PhD, ATC
David E. Martin is a research assistant professor in the Department of Radiology at the University of Virginia Health Sciences Center. He was a doctoral student in Sports Medicine at the University of Virginia at the time of this study. "
https://www.newspapers.com/image/833236235/?terms=%22mosaic%20technologies%22&match=1
By: Reed Williams Observer Staff Writer
https://www.newspapers.com/image/613000984/?terms=%22dave%20winer%22&match=1
By: Reed Williams Daily Progress Staff Writer
By: Reed Williams Daily Progress Staff Writer
Rayburn House Office Building Testimony of Dr. David Martin, CEO, M·CAM Inc. :
I would like to thank you and your distinguished colleagues on the Judiciary Committee for giving me an opportunity to address the topic of patent quality in the United States.
While once deemed badges of intellectual honor, patents have become the currency of the U.S. and global economies. Echoing the debates over a currency standard 100 years ago the United States Congress now faces an issue much more challenging than a decision on gold or silver.
The basis of our economy, no longer tangible metals, is now the national product of the human mind – innovation. The protection of this precious asset is the basis for the intellectual property laws of the United States and the developed world. However, in the past decade we have seen the erosion of confidence in patents. While many conveniently dismiss this as inevitable because that which is intangible cannot be measured, I will provide evidence that confidence is evaporating because the assets are indefensible due to egregious inadequacies in patent prosecution and examination.
In January 2001, on a single trading day, one U.S. company and its investors lost over $330,000,000[1] as a result of misappropriated reliance on U.S. Patents. The patents that Transkaryotic Therapies Inc (TKTX) owned had significant deficiencies in uncited prior art which were overlooked in prosecution and examination. Relying on uninformed patent advice and confidence afforded by questionable patents, they challenged the validity of patents held by Amgen and lost. Our company, using our web-based patent examination system published a projected outcome of this case in November 2000 before anyone in the securities industry or in the courts would commit to the probable direction of the decision. Careful examination of the protected intellectual property in this case show that the TKT deficiency was avoidable had the U.S. Patent Office thoroughly examined prior art. The whole of USPTO
N OTE : https://scrip.citeline.com/deals/200510084
09 May 2005
Shire Pharmaceuticals Group PLC has signed a definitive agreement to purchase Transkaryotic Therapies (TKT; protein replacement therapies for rare genetic diseases) for $1.57bn in cash. Shire will buy TKT's fully diluted shares for $37 each, a 31% premium to the average market price.
Corpus ID: 167987568
PATENT LITIGATION RISK-SCORING MODEL
Alexie Kim, Nicholas W. Partee, Teddy J. Reynolds, Michael A. Santamaria, Faculty Advisor, P. Beling, David V. Ferron, David Winer, Douglas Woolley
Published 2002
Law
We develop a model to predict the probability of a patent being involved in litigation in the near future. Litigation is defined as a legal filing, either offensive or defensive in nature. The model will be used by insurance companies to better evaluate potential clients for intellectual property insurance with a coverage time of two years. The data for the model are from a random sample of all patent case filings from 1994 through 2000. We added a control group of patents not involved in litigation that are similar to the litigated patents. We gather potentially predictive variables about the patent and its owner to build the data set for regression. A logistic regression model is built in SAS using stepwise regression.
https://www.m-cam.com/author/mcam-admin/page/49/
2023-09-12-www-m-cam-com-author-mcam-admin-page-49.pdf
https://drive.google.com/file/d/1DaAaK4w0oOSwPF7ts3vBfSxUURkF8BQE/view?usp=drive_link
2023-09-12-www-m-cam-com-author-mcam-admin-page-49-text.txt
https://drive.google.com/file/d/16NcHVxGilQX-K8828VLDeluU3PXGn9He/view?usp=drive_link
July 23, 2002 In News Archive
Breach Of Contract — The True Failure Of The Patent System
Dr. David E Martin, CEO, M·CAM, Inc. July 27, 2002
Business name: M-CAM, Charlottesville, Va.; founded in 1997.
Business description: Engineers and sells products and services to verify the uniqueness, risks and commercial use of intellectual property.
On the spirit of entrepreneurship:
"I lost my legs in a very serious accident. I learned a lot of skills about adapting to life's circumstances when you go from being an athlete - a runner for the Goshen College track team - to a wheelchair. It has a way of teaching you an awful lot about life.
"I think that the ability to be extremely confident in the mission that you have taken on and the ability to see the mission, in spite of all the obstacles, is really a critical success factor. And I think another is a bit of tenacity.
"M�CAM does something that hasn't been done before, and is bringing the gold standard into an arena that never had one. When one can measure and audit that which was intangible - unmeasurable and unauditable - a sea change occurs. Given that M�CAM has developed the ability to be the rating agency to assess the business and financial risk of assets in a knowledge economy, all traditional service providers and practioners, those who have lived up to this time without any audit, are necessarily affected. Many of them mount a concerted effort to stifle reform and change. A few embrace the changing winds. As with any evolutionary process, certain legacy constituents find their 'high priest' status no longer relevant. But this is not new. The same thing occurred when civilization realized that it was the shadow of the moon that made an eclipse, not some giant serpent taking a bite out of the sun! I'm sure, back then, it was a bad day to be an astrologer!
"We get to interact with both business and public policy makers as a normal course of business, which [is] quite enjoyable but that can also make it frustrating, because anytime that you are dealing with changing paradigms you have obviously a considerable amount of resistance to change and that is something that takes a long time and a lot of effort. That is probably the greatest enjoyment and the greatest frustration.�
David's major was : Interdisciplinary
https://www.finance.senate.gov/imo/media/doc/dmtest031605.pdf
https://www.wipo.int/meetings/en/2006/scp_of_ge_06/speakers/martin.html
Dr. David Martin is the founding CEO of M∙CAM Inc. M∙CAM is the international leader in intellectual property-based financial risk management. From auditing patent quality for governments and patent offices, to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.
A spokesperson for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and finance regulatory agencies in the United States, Europe and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions. M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.
Dr. Martin has founded several for-profit and non-profit companies and organizations and serves of several boards. He was the founding CEO of Mosaic Technologies Inc., a company that developed and commercialized advanced computational linguistics technologies, dynamic data compression and encryption technologies, electrical field transmission technology, medical diagnostics, and stealth/anechoic technology. He was a founding member of Japans Institute for Interface Science & Technology. He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the IST (Japan) the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia).
As former Assistant Professor at the University of Virginias School of Medicine, Dr. Martin founded the Universitys first wholly-owned, for-profit, research and development and technology transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginias Center for Innovative Technology on numerous occasions.
Dr. Martins work with the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management in Ahmedabad India has brought unprecedented curricular focus to areas of intangible asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised intellectual property based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, and the United Arab Emirates.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.
2006 (March 06)
https://www.newspapers.com/image/967187986/?terms=%22david%20martin%22&match=1
2006 (Sep 26)
https://www.newspapers.com/image/968078905/?terms=%22david%20e.%20martin%22&match=1
2006-09-26-the-daily-progress-sun-charlottesville-va-pg-c5-clip-david-martin
2006-09-26-the-daily-progress-sun-charlottesville-va-pg-c5-clip-david-martin
https://www.goshen.edu/news/pressarchive/09-11-07-islam-forum.html
GOSHEN, Ind. — Fostering better relationships between companies — and countries — in the West and the Middle East will require setting aside stereotypes and developing a higher level of mutual understanding and trust.
That message was recently delivered at Goshen College by a U.S. business owner, a German banker who helped start the Dubai International Finance Exchange in the United Arab Emirates and an Egyptian scholar with financial interests in the Middle East and Europe.
David E. Martin, a 1989 graduate of Goshen College and the founding chief executive officer of M-CAM, Inc. of Charlottesville, Va., said he has enjoyed doing business in the Middle East because Islamic cultures tend to foster accountability and transparency in business relationships. “I find myself at home in places like Dubai,” he said.
Steffen Schubert, a banker and expert on the financial industry, said the United Arab Emirates welcomes the business contributions and work of all people, regardless of their nationality or religion. Schubert said the United Arab Emirates has become a “true melting pot” as well as an open, relaxed and peaceful society.
Moustapha Ismail Sarhank, a scholar in the interdisciplinary field of leadership, psychology and religion and the honorary chairman of Sarhank Group for Investments, said U.S. companies often incorrectly assume that the U.S. business model is the best in the world and thus treat people from other countries disrespectfully.
In his case, Sarhank said he built a successful company whose value grew from $150 million to $2.3 billion over 15 years. He attributed his success to keeping God at the center of his life, respecting elders, treating employees courteously, relying on the talents of men and women of different faith traditions and keeping an open mind about others.
“I do not have employees. I have colleagues who help me reach objectives,” he said.
Martin, Schubert and Sarhank made their comments during a public forum — titled “Doing Business in the Muslim World: Are Western Leadership Concepts Appropriate in Islamic Cultures?” — that was held Saturday, Sept. 8 at Goshen College. About 125 people attended the forum at the Umble Center, which was moderated by Jan Bender Shetler, a professor of history at the college.
Sarhank said that he took an immediate dislike to Martin when they first met, in the United Arab Emirates, because they had a clash of cultures and personalities. But as they began discussing such values as respect, justice and honor, Sarhank said, they realized that they had much in common, and they have since become as close as brothers.
Sarhank said it’s important to keep an open mind in business dealings. For example, he said that it’s as incorrect for U.S. citizens to assume people from all Muslim nations think and act the same as it is for people from Islamic cultures to assume that all people from the West think and act the same.
Martin, whose company is an international leader in intellectual property-based financial risk management, said that he believes political leadership in the United States has come to be embodied in people capable only of “standing in front of the crowd and yelling the loudest.” Instead, he stated that true leaders are those who embrace dignity, mutual respect, justice and diversity.
Martin, Sarhank and Schubert also said that fostering better business relationships between Western and Islamic cultures would require a greater mutual respect and a willingness to foster personal relationships that will benefit all sides of business deals.
“Going in trying to impose a system is as disrespectful as failing to address somebody by their first name,” Martin said. “Disrespecting cultures and disrespecting countries is as bad or worse as disrespecting individuals. And so our corporate philosophy has been and continues to be you deposit before you withdraw.” His company’s commitment is to address the needs of people in the communities and countries they do business in before making a profit for themselves.
Goshen College President James E. Brenneman said the forum was a stimulating discussion about global business relationships and was timely in light of the sixth anniversary of the Sept. 11, 2001 attacks and at a time when the U.S. military continues to be involved in Afghanistan and Iraq.
“An evening like this provides a model for us to think about being aware of each other’s religious disciplines, respectful of each other’s cultures and being honest about the fact that none of us know everything there is to know,” Brenneman said afterward.
“These three men provided a model of how important relationships can be to the global business community. One does not have to separate their core values from their business practices in order to succeed.”
Both Sarhank and Schubert said that they were impressed by Goshen College, especially its international Study-Service Term program, its emphasis on peace, justice and reconciliation and the Merry Lea Environmental Learning Center, a 1,150-acre nature center owned and operated by the college.
“You have something I think many people would envy,” Sarhank said. “What I have seen here is definitely going to make me want to come back again.”
Martin, who has formed friendships and business relationships with Sarhank and Schubert, said he arranged Saturday’s public forum because he believed the messages delivered would resonate in the community.
“There are more people here who are going to actually take this message and weave it into what they going to do with their life than those who might look at it [just] as an academic exercise.” Martin added that the forum was “a way to reinforce the components of Goshen [College], which are the components which I value.”
The Center for Business and Entrepreneurial Education, the Yoder Public Affairs Lecture Series and the Peace, Justice & Conflict Studies Department sponsored the forum.
https://www.youtube.com/watch?v=FsVOLSfL9WM
M-Cam's David Martin Discusses Technology Patent Fights
Bloomberg Originals
21,925 views Oct 18, 2011
Oct. 18 (Bloomberg) -- David Martin, chairman and founder of M-Cam Inc., talks about patent fights among technology companies and Google Inc.'s proposed acquisition of Motorola Mobility Holdings Inc.
Martin spoke yesterday with Cory Johnson at the Web 2.0 Summit in San Francisco on Bloomberg Television's "Bloomberg West." Bloomberg's Emily Chang also speaks. (Source: Bloomberg)
https://www.fullyliveacademy.com/community/public/posts/87454-the-patent-wars
2021-11-10-fullyliveacademy-com-community-posts-87454-the-patent-wars.pdf
HV0141
https://drive.google.com/file/d/1oycpTN-gKDBCuN1S-XsHrs-n9XJOIOUm/view?usp=drive_link
2021-11-10-fullyliveacademy-com-community-posts-87454-the-patent-wars-img-1.jpg
HV0142
https://drive.google.com/file/d/1HpTkuAsT5v19DpWjenUzFV1w_boiZfXz/view?usp=drive_link
2014-fullyliveacademy-the-patent-wars-1080p-shared-in-2021.mp4
HV013Z
https://drive.google.com/file/d/1AEPWw1yhrOFdkHgibJAwCAfZT1NV5S56/view?usp=drive_link
2014-fullyliveacademy-the-patent-wars-1080p-shared-in-2021-1080p-hits-cover-1.jpg
HV0140
https://drive.google.com/file/d/1NrjPnY85f-iNzsBk6M_SGGZw__ejrZWL/view?usp=drive_link
Kim & David Martin
Nov 10, 2021
The Patent Wars (2014). Did you know that you can patent colors, numbers, plants and animals and that 20 percent of your genes are patented and owned by private corporations? This documentary is a creative investigation that uncovers who profits from intellectual property and who bears the economic and social consequences.
Directed by Hannah Leonie Prinzler, featuring Dr. David E. Martin
(2014) The Patent Wars (film) (Dir by Hannah Leonie Prinzler, featuring David E. Martin)
https://www.m-cam.com/author/mcam-admin/page/13/
May 13, 2015 In News Archive
FOR IMMEDIATE RELEASE
Celgene’s Revlimid® Patents Do Not Withstand Review
CHARLOTTESVILLE, VA – On May 7, 2015, the European Patent Office revoked one of Celgene’s (NASDAQ: CELG) patents on Revlimid®. Revlimid® reportedly accounts for almost $5 billion of Celgene’s nearly $7.5 billion in annual revenue and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cancer and other autoimmune diseases.
A systematic and rigorous review of the available precedent information, undertaken by M·CAM, provides a sound basis for the invalidation of many other Revlimid® patents, including those currently listed in the FDA’s Orange Book, on the grounds that they are based on an older drug and that the use of the drug in the treatment of cancer was obvious. If the invalidation of the entire Revlimid® portfolio were systematically pursued by a third party, it could materially and adversely impact Celgene.
Simply put, the core Revlimid® compound patent, U.S. Pat. No. 5,635,517 (‘517), is and has always been based on an old drug (thalidomide) and the “innovations” on which Revlimid is based, going back to its priority date in 1996, are obvious in light of precedent innovation. As a result, the ‘517 patent should not be entitled to patent protection in the United States or any of the nearly 70 countries where Revlimid® is approved. Since this base patent of the Revlimid® families of patents is not valid, then many of the Revlimid® patents are subject to validity or commercial relevance challenges.
The full report can be found at Harvest Exchange.
Revlimid® and its patent families do not appear to meet the criteria for legitimate patent protection
M∙CAM
May 13, 2015
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10.pdf
https://drive.google.com/file/d/1wT_haOA7jCEN7Aq1OFhW5DlCfKdbhryt/view?usp=drive_link
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10-img-pg-01
https://drive.google.com/file/d/1tTL1ehhvRJWZw6fVHYa1adYc7sIEsYeu/view?usp=drive_link
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10-img-pg-02
https://drive.google.com/file/d/1e37cdl77cbPRwkAZoEupprB6zCq0n_R4/view?usp=drive_link
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10-img-pg-03
https://drive.google.com/file/d/17rv8X7svuxap8LRLbaJKabfmEAa-HZZh/view?usp=drive_link
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10-img-pg-05
https://drive.google.com/file/d/1UG7AQrbh9sw1wr-SBITnAFWU8inNTSKg/view?usp=drive_link
2015-05-13-m-cam-celgene-revlimid-validity-review-downloaded-by-mkulacz-2023-09-10-img-pg-06
https://drive.google.com/file/d/1Vw73LwcodC9CP8KhZQmtBIO1sJOgwZxX/view?usp=drive_link
Until recently best known as the founder of M·CAM®, the international leader in innovation finance, trade, and intangible asset finance, David E. Martin is a modern day renaissance man, whose roles have included Professor, Lecturer, Chairman and CEO.
From the halls of parliament to HBO comedy and documentary films such as the internationally acclaimed and multi-awarded Patent Wars and Future Dreaming, Dr. Martin takes on some of the world’s most complex economic and social themes using solutions that he’s successfully deployed in his work with over 160 countries.
He recently appeared in Mikki Willis’ documentary, Plandemic: Indoctornation where he revealed the truth behind the vaccine agenda and how following the money had led him to a number of conclusions about what is really going on during the Coronavirus crisis.
With Plandemic: Indoctornation being viewed over 5.7 million times on the Digital Freedom Platform alone, David has become an important voice as part of informed discourse around Coronavirus and our response as a society, with his recent research continuing to focus on vaccines, patents and the role of companies such as Moderna.
David’s other work includes financial engineering and investment, public speaking and writing, he has also served as an advisor to numerous Central Banks, global economic forums, the World Bank and International Finance Corporation and national governments around the world.
He has been instrumental in rebuilding lives and livelihoods in post-conflict, post-colonial, and environmentally devastated regions of the world. He is the architect for the world’s first public equity quantitative market index based on human innovation.
Dr. Martin has publications in law, medicine, engineering, finance, and education. He maintains active research in the fields of linguistic genomics, fractal financial-risk modelling, and cellular membrane ionic signaling. In a televised speech in 2006, David correctly forecast the U.S. housing financial crisis and identified it as a catalyst for the 2008 Global Financial Crisis.
His investment funds, banking businesses and global trade network return extraordinary results by measuring all the field effects of every endeavour. He is also the author of the novel Coup D’Twelve: The Enterprise that Bought the Presidency – now optioned for theatrical release.
Described as a futurist, fulcrum ninja, economist and global business executive, David disarms the most ardent pessimists, showing that with a flexible perspective, we can tackle any perceived problem and achieve extraordinary outcomes.
https://freeadelaide.org/resources/the-fauci-covid-19-dossier/
Original video here (but it has serious audio level issues ... very difficult to listen to) https://www.youtube.com/watch?v=rEe8-Nky1ns
Dr. David Martin and his wife Kim discuss their story and why their message must get out. What we need to know, why Utah matters and how we can make a difference
https://climateinvesting.nd.edu/speakers/david-martin/
Dr. David E. Martin’s full list of qualifications, accolades and experience is an impressive read. The Founder of M·CAM®, the international leader in innovation finance, trade, and intangible asset finance, he is also actively engaged in global ethical economic development.
From the halls of parliaments to HBO comedy, Dr. David Martin takes on some of the world’s most complex economic and social themes using solutions that he’s successfully deployed in his work with over 160 countries.
With current work including financial engineering and investment, public speaking and writing, he has also served as an advisor to numerous Central Banks, global economic forums, the World Bank and International Finance Corporation and national governments around the world.
Dr. Martin has publications in law, medicine, engineering, finance, and education. He maintains active research in the fields of linguistic genomics, fractal financial-risk modelling, and cellular membrane ionic signalling.
In a televised speech in 2006, David correctly forecast the U.S. housing financial crisis and identified it as a catalyst for the 2008 Global Financial Crisis. His investment funds, banking businesses and global trade network return extraordinary results by measuring all the field effects of every endeavour.
Described as a futurist, fulcrum ninja, economist and global business executive, David disarms the most ardent pessimists, showing that with the right perspective, we can tackle any perceived problem and achieve extraordinary outcomes.
His family is an inextricable part of all of his life's endeavors and their activities and passions span the globe.
https://uscnpm.org/2023/06/01/popular-in-china-david-martins-covid-misinformation/
ANALYSIS
Who is David Martin? COVID Conspiracist takes Chinese Social Media by Storm
by USCNPM Staff June 1, 2023
Misinformation surrounding the origins of COVID-19 is a popular topic on Chinese social media, particularly as Chinese state media seeks to deflect scrutiny from the Chinese government’s mishandling of the initial outbreak. Over the past week, a widely viewed video on Chinese social media suggests that COVID-19, along with SARS, are bioweapons engineered by the United States. The video features Dr. David Martin, an American financial analyst, former professor, self-help entrepreneur, and conspiracy theorist, speaking to a supposedly official European Union Summit. Both Dr. Martin’s conspiratorial claims and the officialism of the summit, however, deserve scrutiny. On May 3rd, 2023 a small cohort of Members of the European Parliament (MEPs) gathered in Brussels for the third annual International COVID Summit (ICS). As described by a public group on Facebook, the ICS is a summit where ‘top world doctors and scientists are exposing the truth about the Covid-19 pandemic and the about the upcoming terrors that will attempt to remove our freedoms.’ The group also platforms content related to anti-lockdown and anti-vaccination protests.
The first ICS took place in 2021 after being established by MEPs belonging mostly to right-leaning, populist parties. The unofficial Summit invites public health experts from across the world to provide 15–30-minute presentations on a topic of their choice related to the broader COVID pandemic. However, what unites these various presentations and really every participant in the conference is their collective skepticism of proven scientific facts associated with the pandemic and overall criticism of the world’s reaction to the pandemic. Each speaker, many of whom have relied on data and statistics that have been widely discredited, has typically connected their presentation back to the broader theme that policies associated with the pandemic have unjustly robbed people of their liberty and freedoms. If the audience was made up solely of MEPs, then there were at least 70 of them in attendance at the unofficial 2023 summit. The MEPs who helped organize and spoke at the summit include Romania’s Cristian Terhes, Italy’s Francesca Donato, Germany’s Christine Anderson and Croatia’s Ivan Sinčić and Mislav Kolakušić. While finding full recordings of the 2023 ITC was especially difficult given its unofficial nature, MEP Terhes posted a two-part recording of the full summit on his YouTube page (Part One and Part Two).
In his 20-minute presentation to the summit, Martin argued that the U.S. government and leading vaccine-maker Pfizer nefariously manufactured and released coronavirus before both the 2003 SARS pandemic and COVID-19 pandemic in order to ensure that the world would accept a universal vaccine template. While he claimed to present evidence of U.S.-sponsored biological terrorism on slides during his presentation, none of the summit recordings showed these slides and therefore leave most of his claims without proof of hard evidence for viewers.
Martin has gained a cult-like following on Chinese social media over the last few days because the content of his speech confirms a China preferred narrative that the U.S. biolabs around the world are culprits of one of the worst pandemics in human history. This was partially demonstrated, for example, by one of the U.S.-China Perception Monitor’s surveys, which showed that a majority of Chinese netizens believe Russian conspiracy theories about the discovery of American biolabs in Ukraine. One Chinese netizen, who goes by Milan Noble Warrior (米兰大侠) added Chinese subtitles to Martin’s presentation and reposted it onto Baidu on May 29th. After being on the internet for just one day, the post already has over 8,000 comments, 27,000 likes, and 640,000 total views. Many of the netizens’ comments praised Milan Noble Warrior for posting the video and applauded Martin as a hero exposing what they believe to be the ugly truth about the United States.
Martin’s background warrants scrutiny. He has few discernable ties to China (other than advising some financial firms in mainland China), so his sudden popularity surge on Chinese social media likely has more to do with the content of his message rather than some prior political connection. Martin has published multiple self-help books, hosted a 2013 TED Talk presentation about finance, and played a starring role in the 2020 conspiracy theory-based documentary “Plandemic: Indoctornation”, and has appeared as a guest analyst on networks including CNBC and Bloomberg. He is perhaps most well-known for his YouTube channel. His content regularly features conspiracies related to vaccines, mask-wearing, and other health measures. Some of his videos have been taken down for violating YouTube’s terms of service. He’s posted 275 videos and has nearly 65,000 subscribers, and a big reason for this is due to the popularity of his weekly series titled “Butterfly of the Week”.
Started in 2009, this series covers topics ranging from religion to self-help and wellness but also incorporates a strong conspiratorial element associated with COVID-19. Martin’s wife, Kim, is a registered nurse, consultant, and free-lance self-help expert from Australia and she typically co-hosts episodes with him. While Kim Martin does not seem to have the same media and business-generated fame as her husband, they both have shared in numerous videos that she convinced him to start sharing his thoughts to the public particularly since the pandemic began given their skepticism of it.
The virality of Martin’s speech has provided the small and relatively unknown ICS with significant publicity across YouTube and social media. Overall, Martin’s conspiracy theories lack scientific foundation, yet he’s still been able to disseminate his misinformation primarily through his mostly uncensored YouTube videos. His ICS speech, despite not providing any visual video evidence for his shocking claims, has attracted the attention of hundreds of thousands of Chinese netizens because his views reflect the preferred narrative put forward by the Chinese government that the COVID pandemic may have originated in the United States and not China. In addition, the name brand associated with the European Parliament, even if the ICS summit is not an official EU event, helped make the conference and thus Martin’s platform seem widely accepted within the governing body even though it was not. Chinese social media outlets and officials tend to use foreign sources of information to spread its preferred narrative, and this could be yet another example of this tactic. There is no doubt that conspiracy theories such as the ones Martin has leveled are exactly the kinds of dangerous sources of influence that compromise people’s health and put lives at risk.
In the recently released interview linked below—which consists of a candid question-and-answer interview with David E. Martin, PhD, the founding CEO of M∙CAM Inc.—we at Catholic Business Journalwere unanimous in our appreciation for such well-researched, objective, logical and CLEAR tracking of the origins of the SARS-CoV-2 (Covid-19) virus.
The video is a bit long, but absolutely worth it to the end.
We’ve never seen any of this information anywhere else in the news and David E. Martin, PhD — given his extensive research background serving the highest levels of intelligence agencies and his extensive access to data and patents— delivers in a calm, logical way with facts ONLY.
Click on the video image below (or here) to watch video
In case you are wondering, below please find more information on David E. Martin, Ph.D, who is featured in the video, and more about his company, culling from the World Intellectual Property Organization for which he has been a speaker..
M∙CAM is the international leader in intellectual property-based financial risk management.
From auditing patent quality for governments and patent offices, to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.
A spokesperson for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and finance regulatory agencies in the United States, Europe and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions.
M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.
Dr. Martin has founded several for-profit and non-profit companies and organizations and serves of several boards.
He was the founding CEO of Mosaic Technologies Inc., a company that developed and commercialized advanced computational linguistics technologies, dynamic data compression and encryption technologies, electrical field transmission technology, medical diagnostics, and stealth/anechoic technology. He was a founding member of Japan’s Institute for Interface Science & Technology.
He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the IST (Japan) the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia).
Click on the video image below (or here) to watch video
As former Assistant Professor at the University of Virginia’s School of Medicine, Dr. Martin founded the University’s first wholly-owned, for-profit, research and development and technology transfer corporation.
Engaged in domestic and international technology transfer, clinical research and financing, this company pioneered new techniques innovation management that have become industry standards.
In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia’s Center for Innovative Technology on numerous occasions.
Dr. Martin’s work with the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management in Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible asset risk management, finance, and accounting standards.
In addition to his academic work, Dr. Martin has closely advised intellectual property based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, and the United Arab Emirates.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.
VIDEO: A Manufactured Illusion, with Dr. David E. Martin, PhD, and interviewer Reiner Fuellmich, recorded on July 9, 2021 — this is a bit long, but worth it… It is the best tracking of the origins of SARS-CoV-2 we have seen… absolutely objective, logical, follows the patents. Quite interesting. Very clear.
admits - born in 1967 ...
(2023 - 1967 = 56 )
OIRE - https://www.techarp.com/tag/david-martin/
He doesnt mention Waterson ....
DIRECTORY INFO
Saved as PDF : [HD004K][GDrive]
Name : David E Martin / [Dave Martin] / [David B Martin]
Birth Date : Apr 1967
Residence Date : 2005-2020
Address : 1854 Rhett CT / Charlottesville, Virginia, USA / 22903
Second Residence Date : 2005-2007
Second Address : 1040 Tupelo CT / Charlottesville, Virginia, USA / 22903
Third Residence Date : 1993-2006
Third Address : 125 Mill Creek Dr / Charlottesville, Virginia, USA / 22902
Fourth Residence Date : 1997-2000
Fourth Address : 414 East Market St Ste B / Charlottesville, Virginia, USA / 22902
04.24.67 is his birth date. His age is 56. Nine alternative names are known: Dave Martin, Dave E Martin, David Martin, D Martin, David B Martin, David M Martin, Davide Martin, David C Martin, David E Thomas. 1854 Rhett Crt, Charlottesville, VA 22903-8805 is the residential address for David. We know about one company registered at this address — M-cam Global Holdings LLC. Colleen C Martin, Katherine I Martin, and two other persons are connected to this place. David has visited nine cities, 405 S Morrison Rd, Muncie, IN 47304, USA is the previous address. David has lived in Muncie, IN and Charlottesville, VA. Katie Hershberger Boryan, Andrew Joseph Boryan, Kay L Geisel are possible acquaintances of David because of the common address history. Here are his most likely phone numbers: [---]. Two persons, including Colleen C Martin, Zachary W Martin, listed the phone number [---] as their own, various documents indicated. Public records show that the phone number [---] is linked to Katherine I Martin, Zachary W Martin. Three email addresses were found in public records and on the web — dem@mcam.com, dmartin@m-cam.com, martmosaic@mindspring.com. [---]
[...]
When was David E Martin born? David Martin is 56. He was born on Apr 24, 1967.
What are the other possible names for David E Martin? The most common alternative names for he are David E Thomas, David C Martin, Davide Martin, David M Martin, David B Martin, D Martin, David Martin, Dave E Martin, Dave Martin.
What is the last known address for David E Martin? 1854 Rhett Crt, Charlottesville, VA 22903-8805 is the last known address for David.
Who are the residents at 1854 Rhett Court Charlottesville, in addition to David E Martin? We assume that Colleen C Martin and Katherine I Martin were among four dwellers or residents at this place.
Where did David E Martin formerly reside? Nine previous addresses found, including 405 S Morrison Rd, Muncie, IN 47304, USA.
[...]
How old is Katherine I Martin? Katherine Martin is 34. Katherine was born on Jul 28, 1989.
Where does Katherine I Martin reside? Current address for Katherine is 1854 Rhett Crt, Charlottesville, VA 22903-8805.
Who else lives with 1854 Rhett Court Charlottesville at 1854 Rhett Court Charlottesville? This address is also associated with the names of Colleen C Martin, David E Martin, and two other individuals.
https://www.whitepages.com/name/Katherine-Irene-Martin/Charlottesville-VA/Pg3bkYpqq86
Katherine Irene Martin (Katherine Martin Lloyd, Katie Martin)
BIRTHDATE : 7/28/1989 (34yrs)
LOCATION : Charlottesville, VA
https://www.events.pfsglobal.com/david-martin
Dr. David E. Martin | M·CAM International
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Dr. David E. Martin is the Founder and Chairman of M·CAM International., the global leader in innovation finance, trade, and intangible asset finance. He is the developer of the first innovation-based quantitative index of public equities and is the Managing Partner of the Purple Bridge Funds. He is the creator of the world’s first quantitative public equity index – the CNBC IQ100 powered by M·CAM which is now reported by The Conference Board as U.S. and Global Leading Economic Indicators. He manages three Exchange Traded Funds (NYSE:INAU; NYSE:INAG; and NYSE:TWAR). Actively engaged in global ethical economic development, Dr. Martin's work includes financial engineering and investment, public speaking, writing and providing financial advisory services to the majority of countries in the world. Dr. Martin is the architect and founder of the Global Innovation Commons and is the author of the international legal framework for the Heritable Knowledge Trust and Heritable Innovation Trust programs. He has pioneered global programs to bring corporate and stock market transparency to multi-national extractive industries and has been instrumental in repatriating value to countries which have been subject to corporate and financial abuses. His work on ethical engagement and stewardship of community and commons-based value interests is at the forefront of global financial innovation. Dr. Martin is a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration. He served as Chair of Economic Innovation for the UN-affiliated Intergovernmental Renewable Energy Organization and has served as an advisor to numerous Central Banks, global economic forums, the World Bank and International Finance Corporation, and national governments.
A spokesperson for global financial and intangible asset accountability and quality reform, Dr. Martin has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States, Europe, and Asia in advocating and deploying infrastructure to support growing reliance on contract and proprietary rights in business transactions. Under the leadership of Dr. Martin, M·CAM has supported the modernization of banking, intangible asset, tax, and accounting laws through its work with oversight agencies and policy makers.
Dr. Martin has founded several for-profit and not-for-profit companies and organizations and serves on several boards. He is a Co-Chair of the ADC (Australia Davos Connection) Forum’s Leadership Retreat and Critical Infrastructure and Cybersecurity Councils. He was the founding Director of Melbourne’s Centre of Applied Innovation. He served as Chairman and CEO of eSurface®. He was the founding CEO of Mosaic Technologies, Inc., a company that developed and commercialized technologies in advanced computational linguistics, dynamic data compression and encryption, electrical field transmission, medical diagnostics, and stealth/anechoics. He was a founding member of Japan's Institute for Interface Science and Technology (IIST). He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington, D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia), Humanitad (U.K), Global Urban Development, and many other agencies dedicated to ethical human development. As international policy contributor, economist and futurist, Dr. Martin’s work at The Arlington Institute (U.S.) included accurately forecasting the global financial crisis of 2008 and working with the launch of Singapore’s Risk Assessment Horizon Scanning initiative.
Dr. Martin's work as a Fellow of the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible-asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised innovation-based finance and investment programs in India, Bermuda, Brazil, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, Mongolia, Egypt, Ecuador, Singapore, Germany, Slovenia, Vietnam, and the United Arab Emirates. He has served as the Constitutional and Economic advisor to the Autonomy Committee of East New Britain and New Ireland, Papua New Guinea and has worked with ethical trade frameworks for the Kingdom of Tonga, the Independent State of Samoa, Fiji, and Papua New Guinea.
His work has been the subject of two internationally awarded documentaries, Patent Wars which highlights his work on reform of the global innovation system and Future Dreaming: A Conversation with David Martin which is a dialogue about humanity and its optimal interaction in the universe. He has spoken at the United Nations General Assembly on citizen-led peacemaking initiatives and has been featured on Bloomberg television and HBO’s Last Week Tonight with John Oliver.
A speaker, author, business executive and futurist, Dr. Martin’s work has been engaged in every country on Earth. He works with his family in every endeavor of life. Together with his wife Kim, he directs the Breathing Enterprise workshops and facilitates implementation of Integral Accounting. Dr. Martin received his undergraduate (BA) from Goshen College, his Masters of Science from Ball State University, and his Doctorate (PhD) from the University of Virginia.